Phathom Pharmaceuticals Ownership | Who Owns Phathom Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Phathom Pharmaceuticals Ownership Summary


Phathom Pharmaceuticals is owned by 96.89% institutional investors, 7.70% insiders. Frazier life sciences management is the largest institutional shareholder, holding 17.32% of PHAT shares. Invesco OFI Global Equity is the top mutual fund, with 2.89% of its assets in Phathom Pharmaceuticals shares.

PHAT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPhathom Pharmaceuticals96.89%7.70%-4.58%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management10.11M17.32%$104.13M
Medicxi ventures management (jersey)7.46M12.79%$76.89M
Carlyle group3.50M5.99%$35.84M
Invesco3.14M5.39%$32.38M
Blackrock2.93M5.01%$30.14M
Jennison associates2.76M4.72%$28.40M
Ensign peak advisors2.24M3.85%$23.12M
Vanguard group2.21M3.79%$22.78M
Nea management company1.96M3.36%$20.19M
Avidity partners management lp1.62M2.78%$16.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Medicxi ventures management (jersey)7.46M22.93%$76.89M
Propel bio management869.93K5.81%$8.96M
Catalys pacific721.96K5.61%$7.44M
Checkpoint capital875.00K5.43%$9.01M
Frazier life sciences management10.11M4.87%$104.13M
Carlyle group3.50M3.40%$35.84M
Decheng capital850.00K2.68%$8.76M
Saturn v capital management593.31K2.31%$6.11M
Oracle investment management225.00K2.16%$2.32M
Ghost tree capital600.00K1.94%$6.18M

Top Buyers

HolderShares% AssetsChange
Portolan capital management1.13M0.96%1.13M
Jennison associates2.76M0.02%1.11M
Morgan stanley762.60K0.00%525.44K
Gilder gagnon howe1.47M0.19%454.64K
Checkpoint capital875.00K5.43%429.84K

Top Sellers

HolderShares% AssetsChange
Octagon capital advisors lp---455.00K
683 capital management1.40M1.09%-250.00K
Millennium management---225.02K
Newtyn management---165.00K
Two sigma investments, lp303.43K0.01%-164.02K

New Positions

HolderShares% AssetsChangeValue
Portolan capital management1.13M0.96%1.13M$11.64M
Prudential financial352.34K0.01%352.34K$3.63M
Oracle investment management225.00K2.16%225.00K$2.32M
Mml investors services19.60K0.00%19.60K$202.00K
Corebridge financial18.36K0.00%18.36K$189.09K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-7.00
Bessemer group-325.00
Aquatic capital management-500.00
Vestcor-548.00
Ica group wealth management-1.30K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024115-1.71%56,555,1598.24%961.17%6624.53%19-44.12%
Mar 31, 2024117-2.50%52,249,16711.99%911.35%53-28.38%3447.83%
Dec 31, 20231206.19%46,653,5756.61%821.01%7417.46%23-4.17%
Sep 30, 20231134.63%43,760,2702.29%900.88%63-7.35%2420.00%
Jun 30, 202310824.14%42,778,86638.95%1011.91%6841.67%205.26%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Invesco OFI Global Equity1.98M2.89%252.08K
Invesco Global A1.98M2.89%-
Jennison Health Sciences Equity1.97M2.89%482.19K
PGIM Jennison Health Sciences Z1.97M2.89%-
Vanguard Total Stock Mkt Idx Inv1.65M2.41%2.38K
Strategic Advisers U.S. Total Stock{mg}1.48M2.16%-273.72K
PGIM Jennison Small Company A1.42M2.08%560.99K
Fidelity Select Biotechnology1.30M1.91%1.30M
Strategic Advisers Small-Mid Cap1.24M1.82%278.88K
iShares Russell 2000 ETF876.30K1.28%-1.97K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 15, 2024Nabulsi Azmi Chief Operating OfficerSell$127.76K
Jul 15, 2024Henderson Molly CFO and CBOSell$50.69K
Jul 15, 2024Curran Terrie President and Chief ExecutiveSell$396.70K
Apr 08, 2024Henderson Molly CFO and CBOSell$38.13K
Mar 22, 2024Curran Terrie President and Chief ExecutiveSell$153.51K

Insider Transactions Trends


DateBuySell
2024 Q3-3
2024 Q2-1
2024 Q1-3
2023 Q433
2023 Q3--

PHAT Ownership FAQ


Who Owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals shareholders are primarily institutional investors at 96.89%, followed by 7.70% insiders and -4.59% retail investors. The average institutional ownership in Phathom Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Phathom Pharmaceuticals exceeds.

Who owns the most shares of Phathom Pharmaceuticals?

Phathom Pharmaceuticals’s largest shareholders are Frazier life sciences management (10.11M shares, 17.32%), Medicxi ventures management (jersey) (7.46M shares, 12.79%), and Carlyle group (3.5M shares, 5.99%). Together, they hold 36.10% of Phathom Pharmaceuticals’s total shares outstanding.

Does Blackrock own Phathom Pharmaceuticals?

Yes, BlackRock owns 5.01% of Phathom Pharmaceuticals, totaling 2.93M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.14M$. In the last quarter, BlackRock increased its holdings by 180.99K shares, a 6.59% change.

Who is Phathom Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Medicxi ventures management (jersey) is Phathom Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 22.93% of its assets in 7.46M Phathom Pharmaceuticals shares, valued at 76.89M$.

Who is the top mutual fund holder of Phathom Pharmaceuticals shares?

Invesco OFI Global Equity is the top mutual fund holder of Phathom Pharmaceuticals shares, with 2.89% of its total shares outstanding invested in 1.98M Phathom Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools